Gout

61
GOUT GOUT Wayne Blount, MD, MPH Wayne Blount, MD, MPH Professor, Professor, Emory Univ. S.O.M. Emory Univ. S.O.M.

description

referat gout

Transcript of Gout

  • GOUT

    Wayne Blount, MD, MPHProfessor,Emory Univ. S.O.M.

  • OBJECTIVESIdentify diagnostic criteria for gout

    Identify 3 treatment goals for gout

    Name the agents used to treat the acute flares of gout and the chronic disease of gout

  • Why Worry About Gout ?Prevalence increasingMay be signal for unrecognized comorbidities : ( Not to point of searching)

    Obesity (Duh!)Metabolic syndromeDMHTNCV diseaseRenal disease

  • URATE, HYPERURICEMIA & GOUT

    Urate: end product of purine metabolism

    Hyperuricemia: serum urate > urate solubility (> 6.8 mg/dl)

    Gout: deposition of monosodium urate crystals in tissues

  • HYPERURICEMIA & GOUT

    Hyperuricemia caused byOverproductionUnderexcretion

    No Gout w/o crystal deposition

  • THE GOUT CASCADE UrateOevrproductionUnderexcretion

    Hyperuricemia

    ________________________________________

    SilentGoutRenalAssociatedTissue manifestationsCV events &Deposition mortality

  • GOUT: A Chronic Disease of 4 stages

    Asymptomatic hyperuricemia

    Acute Flares of crystallization

    Intervals between flares

    Advanced Gout & Complications

  • ACUTE GOUTY FLARESAbrupt onset of severe joint inflammation, often nocturnal;Warmth, swelling, erythema, & pain;Possibly feverUntreated? Resolves in 3-10 days90% 1st attacks are monoarticular50% are podagra

  • SITES OF ACUTE FLARES90% of gout patients eventually have podagra : 1st MTP joint

  • SitesCan occur in other joints, bursa & tendons

  • INTERVALS SANS FLARESAsymptomatic

    If untreated, may advance

    Intervals may shortenCrystals in asx jointsBody urate stores increase

  • FLARE INTERVALSSilent tissue deposition & Hidden Damage

  • ADVANCED GOUTChronic Arthritis

    X-ray Changes

    Tophi Develop

    Acute Flares continue

  • ADVANCED GOUTChronic ArthritisPolyarticular acute flares with upper extremities more involved

  • TOPHISolid urate deposits in tissues

  • TOPHIIrregular & destructive

  • TOPHI RISK FACTORS

    Long duration of hyperuricemia

    Higher serum urate

    Long periods of active, untreated gout

  • RADIOLOGIC SIGNS

  • X-RAYS

  • X-RAYS

  • DIAGNOSING GOUT

    Hx & P.E.

    Synovial fluid analysis

    Not Serum Urate

  • SERUM URATE LEVELSNot reliable

    May be normal with flares

    May be high with joint Sx from other causes

  • GOUT RISK FACTORSMalePostmenopausal femaleOlderHypertensionPharmaceuticals:Diuretics, ASA, cyclosporine

  • GOUT RISK FACTORSTransplantAlcohol intakeHighest with beerNot increased with wineHigh BMI (obesity)Diet high in meat & seafood

  • SYNOVIAL FLUID ANALYSIS (Polarized Light Microscopy)The Gold standard

    Crystals intracellular during attacks

    Needle & rod shapes

    Strong negative birefringence

  • SYNOVIAL FLUID

  • DIFFERENTIAL DIAGNOSIS

    Pseudogout: Chondrocalcinosis, CPPDPsoriatic ArthritisOsteoarthritisRheumatoid arthritisSeptic arthritisCellulitis

  • Gout vs. CPPD

    Similar Acute attacks

    Different crystals under Micro;Rhomboid, irregular in CPPD

  • Gout vs CPPD

  • RA vs Gout

    Both have polyarticular, symmetric arthritis

    Tophi can be mistaken for RA nodules

  • RA vs Gout

  • REDNECK MEDICAL TERMS

    BENIGN : WHAT YOU BE AFTER YOU BE EIGHT

  • TREATMENT GOALS

    Rapidly end acute flaresProtect against future flaresReduce chance of crystal inflammation

    Prevent disease progressionLower serum urate to deplete total body urate poolCorrect metabolic cause

  • ENDING ACUTE FLARESControl inflammation & pain & resolve the flareNot a cureCrystals remain in jointsDont try to lower serum urate during a flareChoice of med not as critical as alacrity & duration EBM

  • Acute Flare Med Choices

    NSAIDS

    Colchicine

    Corticosteroids

  • MED ConsiderationsNSAIDS : Interaction with warfarinContraindicated in:Renal diseasePUDGI bleedersASA-induced RAD

  • MED ConsiderationsColchicine :Not as effective late in flareDrug interaction : Statins, Macrolides, CyclosporineContraindicated in dialysis pt.sCautious use in : renal or liver dysfunction; active infection, age > 70

  • MED Considerations

    Corticosteroids :Worse glycemic controlMay need to use mod-high doses

  • TREATMENT GOALSRapidly end acute flaresProtect against future flaresReduce chance of crystal inflammation

    Prevent disease progressionLower serum urate to deplete total body urate poolCorrect metabolic cause

  • PROTECTION VS. FUTURE FLARESColchicine : 0.5-1.0 mg/dayLow-dose NSAIDS

    Both decrease freq & severity of flaresPrevent flares with start of urate-lowering RX Best with 6 mos of concommitant RXEBM

    Wont stop destructive aspects of gout

  • TREATMENT GOALSRapidly end acute flaresProtect against future flaresReduce chance of crystal inflammation

    Prevent disease progressionLower serum urate to deplete total body urate poolCorrect metabolic cause

  • PREVENT DISEASE PROGRESSIONLower urate to < 6 mg/dl : DepletesTotal body urate poolDeposited crystals EBM

    RX is lifelong & continuousMED choices :Uricosuric agentsXanthine oxidase inhibitor

  • PREVENT THIS

  • URICOSURIC AGENTSProbenecid, (Losartan & fenofibrate for mild disease)

    Increased secretion of urate into urine

    Reverses most common physiologic abnormality in gout ( 90% pt.s are underexcretors)

  • XANTHINE OXIDASE INHIBITORAllopurinol :Blocks conversion of hypoxanthine to uric acidEffective in overproducersMay be effective in underexcretorsCan work in pt.s with renal insufficiency

  • WHICH AGENT ?AllopurinolUricosuricIssue in renal disease X XDrug interactions X XPotentially fatal hypersen- sitivity syndrome XRisk of nephrolithiasis XMutiple daily dosing X

  • WHICH AGENTBase choice on above considerations & whether pt is an overproducer or underexcretor : Need to get a 24-hr. urine for urate excretion:< 700 --- underexcretor (uricosuric)> 700 --- overproducer (allopurinol)

  • NEW AGENTSRX gaps : Cant always get urate < 6AllergiesDrug interactionsAllopurinol intoleranceWorse Renal disease

  • URICASE ENZYMES (Stay Tuned)

    Catabolize urate to allantoin:More soluble, excretable form

    Currently approved for hypoeruricemia in tumor lysis syndrome

    Some concerns: fatal immunogenicity & unknown long-term effects

  • CASE STUDIES

  • CASE J.F.80 YO W F c/o acute overnight pain & swelling in R kneePE: 51 & 180 lbsR knee swollen, warm & erythematousPMH : HTN x 5 yrsMeds: HCTZ (25 QD) & ASASH : 20 PY smoker; 5 wine drinks/wk

  • WHAT ARE J.F.s RISK FACTORS FOR GOUT ?A. HTNB. SMOKERC. HCTZD. ASAWINE CONSUMPTIONOBESITYAGEPOSTMENOPAUSAL

  • HOW WOULD YOU DX GOUT ?

    A. HX & PE COMPATIBLEB. CHECK SERUM URATE LEVELASSESS SYNOVIAL FLUIDTRIAL OF COLCHICINECHECK X-RAYS

  • IF YOU DX GOUT, WHAT RX TODAY? (& Why?)

    A. MOTRINB. INDOCINC. PREDNISONED. ALLOPURINOLE. PROBENECIDF. COLCHICINE

  • NEXT STEP FOR J.F. ?

    A. Modify risk factorsB. Give refills to rx next flareC. Start colchicine to prevent flaresD. Check serum urate levelE. Start allopurinolF. Start probenecid

  • CASE M.B.

    56 YO W M c/o hand stiffness & growthsPE : 62 & 205 lbsMultiple tophi; chronic arthritisPMH : DM x 8 yrs; gout x4 yrs, but no flares x 3 yrs, lost 20# on Atkins dietMeds: Glyburide; colchicine (0.6 mg TID)Labs: Creat.= 2.0; Urate = 11.4

  • IN WHAT STAGE OF GOUT IS M.B. ?

    A. Doesnt have gout

    B. ASX. Hyperuricemia

    C. Interflare period

    D. Advanced Gout

  • WOULD YOU CHANGE MDS RX ?

    No Not goutNo No flare x 3 yrs.Yes - Increase colchicineYes Add allopurinolYes Add benemid

  • WHAT OTHER ISSUES WOULD YOU CONSIDER ?

    Renal dysfunctionWeightDMGlyburideDiet

  • CONCLUSIONSGout is chronic with 4 stagesUncontrolled gout can lead to severe diseaseSeparate RX for flares & preventing advancementMany meds for flaresTreating the disease requires lowering urateGet a 24-hr urine for urate excretion

  • QUESTIONS